DYN
Dyne Therapeutics Inc
16.00$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | |
| 64.9% | 52.2% | 48.4% | 50.8% | 60.8% | 8,933.3% | 38,166.7% | 78.1% | 240.9% | 167.0% | 579.4% | – | – | – | – | – | – | – | – | |
| 35.1% | 47.8% | 51.6% | 49.2% | 39.2% | -8,833.3% | -38,066.7% | 21.9% | -140.9% | -67.0% | -479.4% | – | – | – | – | – | – | – | – | |
| 6.5% | 4.4% | 6.4% | 7.0% | 8.5% | 733.3% | 3,233.3% | 6.6% | 15.2% | 11.8% | 37.4% | – | – | – | – | – | – | – | – | |
| -6.5% | -13.9% | -21.0% | 7.0% | 8.5% | -2,700.0% | 3,233.3% | -21.0% | 15.2% | 11.8% | 37.4% | – | – | – | – | – | – | – | – | |
| 19.5% | 20.0% | -33.8% | -0.5% | -14.9% | 23,800.0% | -10,600.0% | -21.7% | 7.6% | -46.9% | -81.4% | – | – | – | – | – | – | – | – | |
| 12.4% | 12.0% | 16.8% | 15.6% | 22.5% | 0.0% | 3,233.3% | 4.6% | 64.8% | 45.8% | 121.7% | – | – | – | – | – | – | – | – | |
| 8.6% | 6.9% | -54.9% | -10.1% | -143.7% | 2,900.0% | -13,900.0% | -18.3% | -50.7% | -94.4% | -106.3% | – | – | – | – | – | – | – | – | |
| -4.9% | -2.1% | 12.8% | 8.5% | -39.9% | -20,900.0% | -1,933.3% | 8.0% | -56.3% | -3.3% | -120.6% | – | – | – | – | – | – | – | – | |
| 8.5% | 4.9% | -51.1% | -10.1% | -103.8% | 2,900.0% | -11,866.7% | -4.6% | 5.9% | -90.8% | 15.0% | – | – | – | – | – | – | – | – | |
| 26.7% | 25.4% | -7.0% | 31.6% | -99.3% | 3,766.7% | 5,000.0% | 19.9% | 87.4% | 7.8% | 187.5% | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.